Literature DB >> 8634086

Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats.

H Kitada1, M Tsutsumi, T Tsujiuchi, M Takahama, T Fukuda, N Narita, Y Konsihi.   

Abstract

Point mutations of the Ki-ras and p53 genes in rat lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine (BHP) were investigated by polymerase chain reaction-single strand conformation polymorphism analysis followed by direct sequencing using paraffin-embedded tissues. Male Wistar rats 6 wk old were given 2000 ppm BHP in drinking water for 15 wk. Another group was given drinking water without BHP. The rats were killed 20-27 wk after the beginning of the experiment. Lung adenomatous and squamous lesions, including carcinomas, were induced. The frequencies of Ki-ras mutations were 40% (six of 15) in alveolar hyperplasias, 36% (five of 14) in adenomas, 72% (18 of 25) in adenocarcinomas, 20% (three of 15) in squamous metaplasias, 50% (three of six) in squamous cell carcinomas, and 50% (five of 10) in adenosquamous carcinomas. The mutations were all G-->A transitions at the second position of codon 12; no other mutations were detected. However, Ha-ras mutations in exons 1 and 2 and p53 mutations in exons 5, 6, and 7 were not detected in adenocarcinomas and squamous cell carcinomas. These results indicate that Ki-ras mutation is an early genetic event in some adenomatous and squamous lung carcinogeneses and that Ki-ras mutations can cause benign lesions to convert to malignant lesions. The results also show that Ha-ras and p53 mutations are not involved in rat lung carcinogenesis induced by BHP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634086     DOI: 10.1002/(SICI)1098-2744(199604)15:4<276::AID-MC5>3.0.CO;2-E

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  5 in total

1.  Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway.

Authors:  David Blanco; Silvestre Vicent; Mario F Fraga; Ignacio Fernandez-Garcia; Javier Freire; Amaia Lujambio; Manel Esteller; Carlos Ortiz-de-Solorzano; Ruben Pio; Fernando Lecanda; Luis M Montuenga
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

2.  No Mutations of Lysophosphatidic Acid Receptor Genes in Lung Adenocarcinomas Induced by N-Nitrosobis(2-hydroxypropyl)amine in Rats.

Authors:  Naoko Wakabayashi; Megumu Tsujino; Masaki Tajiri; Midori Taki; Ayumi Koshino; Hiroko Ikeda; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  J Toxicol Pathol       Date:  2010-04-05       Impact factor: 1.628

3.  Genetic and epigenetic alterations of lysophosphatidic Acid receptor genes in rodent tumors by experimental models.

Authors:  Toshifumi Tsujiuchi; Kyoko Okabe; Nobuyuki Fukushima
Journal:  J Toxicol Pathol       Date:  2011-10-12       Impact factor: 1.628

4.  Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.

Authors:  T Tsujiuchi; Y Sasaki; M Tsutsumi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2000-10

5.  Mutations and reduced expression of the transforming growth factor-beta receptor II gene in rat lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine.

Authors:  T Tsujiuchi; Y Sasaki; M Tsutsumi; Y Konishi
Journal:  Jpn J Cancer Res       Date:  2000-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.